Adequacy assessment of endoscopic ultrasound-guided, fine-needle aspirations of pancreatic masses for theranostic studies: Optimization of current practices is warranted

Sarah Navina, Kevin McGrath, Jennifer Chennat, Vijay Prem Singh, Timothy Pal, Herb Zeh, Alyssa M. Krasinskas

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Context.-Novel chemotherapy regimens now provide the opportunity for "personalized" care in pancreatic cancer. Little is known about our ability to procure adequate cells for theranostic studies using standard ultrasound-guided fine-needle aspirations and cytologic techniques. Objective.-To assess cellularity of cytology material in patients with solid pancreatic lesions. Design.-One hundred sixty-nine endoscopic ultrasound- guided fine-needle aspirations with positive diagnoses of solid epithelial pancreatic neoplasms were evaluated for smear and cell block cellularity. Cellularity was scored on a scale of 1 to 4; scores of 3 or 4 (>100 cells) were deemed adequate for ancillary studies. Clinicopathologic variables were recorded. A 3-month prospective analysis was also performed using a new collection algorithm. Results.-Only 12.4% (21 of 169) of the positive cases had a cell block cellularity score that was adequate for theranostic studies. This score was not associated with onsite evaluation, needle gauge, or number of passes. Adenocarcinoma was the most common diagnosis (88%) but yielded fewer adequate cell blocks, P = .006. Cellularity showed correlation with endoscopists, P = .04. Tumor size and fibrosis score of resected tumors tended to correlate with cellularity, but only larger size in endocrine tumors was significantly associated with adequacy (P = .02). Standardized collection did not improve overall cell block cellularity. Conclusions.-Changes in practice, such as obtaining dedicated passes for ancillary studies, may not be enough to improve the theranostic utility of endoscopic ultrasound- guided fine-needle aspiration in pancreatic neoplasia. Other methods to improve tumor cell yield, including modified cytologic techniques and new needle designs, need to be further investigated.

Original languageEnglish (US)
Pages (from-to)923-928
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume138
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Endoscopic Ultrasound-Guided Fine Needle Aspiration
Neoplasms
Pancreatic Neoplasms
Needles
Glandular and Epithelial Neoplasms
Fine Needle Biopsy
Theranostic Nanomedicine
Cell Biology
Adenocarcinoma
Fibrosis
Drug Therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Adequacy assessment of endoscopic ultrasound-guided, fine-needle aspirations of pancreatic masses for theranostic studies : Optimization of current practices is warranted. / Navina, Sarah; McGrath, Kevin; Chennat, Jennifer; Singh, Vijay Prem; Pal, Timothy; Zeh, Herb; Krasinskas, Alyssa M.

In: Archives of Pathology and Laboratory Medicine, Vol. 138, No. 7, 2014, p. 923-928.

Research output: Contribution to journalArticle

@article{08de9773ce9a4355ba2d9b605d018ca1,
title = "Adequacy assessment of endoscopic ultrasound-guided, fine-needle aspirations of pancreatic masses for theranostic studies: Optimization of current practices is warranted",
abstract = "Context.-Novel chemotherapy regimens now provide the opportunity for {"}personalized{"} care in pancreatic cancer. Little is known about our ability to procure adequate cells for theranostic studies using standard ultrasound-guided fine-needle aspirations and cytologic techniques. Objective.-To assess cellularity of cytology material in patients with solid pancreatic lesions. Design.-One hundred sixty-nine endoscopic ultrasound- guided fine-needle aspirations with positive diagnoses of solid epithelial pancreatic neoplasms were evaluated for smear and cell block cellularity. Cellularity was scored on a scale of 1 to 4; scores of 3 or 4 (>100 cells) were deemed adequate for ancillary studies. Clinicopathologic variables were recorded. A 3-month prospective analysis was also performed using a new collection algorithm. Results.-Only 12.4{\%} (21 of 169) of the positive cases had a cell block cellularity score that was adequate for theranostic studies. This score was not associated with onsite evaluation, needle gauge, or number of passes. Adenocarcinoma was the most common diagnosis (88{\%}) but yielded fewer adequate cell blocks, P = .006. Cellularity showed correlation with endoscopists, P = .04. Tumor size and fibrosis score of resected tumors tended to correlate with cellularity, but only larger size in endocrine tumors was significantly associated with adequacy (P = .02). Standardized collection did not improve overall cell block cellularity. Conclusions.-Changes in practice, such as obtaining dedicated passes for ancillary studies, may not be enough to improve the theranostic utility of endoscopic ultrasound- guided fine-needle aspiration in pancreatic neoplasia. Other methods to improve tumor cell yield, including modified cytologic techniques and new needle designs, need to be further investigated.",
author = "Sarah Navina and Kevin McGrath and Jennifer Chennat and Singh, {Vijay Prem} and Timothy Pal and Herb Zeh and Krasinskas, {Alyssa M.}",
year = "2014",
doi = "10.5858/arpa.2013-0335-OA",
language = "English (US)",
volume = "138",
pages = "923--928",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "7",

}

TY - JOUR

T1 - Adequacy assessment of endoscopic ultrasound-guided, fine-needle aspirations of pancreatic masses for theranostic studies

T2 - Optimization of current practices is warranted

AU - Navina, Sarah

AU - McGrath, Kevin

AU - Chennat, Jennifer

AU - Singh, Vijay Prem

AU - Pal, Timothy

AU - Zeh, Herb

AU - Krasinskas, Alyssa M.

PY - 2014

Y1 - 2014

N2 - Context.-Novel chemotherapy regimens now provide the opportunity for "personalized" care in pancreatic cancer. Little is known about our ability to procure adequate cells for theranostic studies using standard ultrasound-guided fine-needle aspirations and cytologic techniques. Objective.-To assess cellularity of cytology material in patients with solid pancreatic lesions. Design.-One hundred sixty-nine endoscopic ultrasound- guided fine-needle aspirations with positive diagnoses of solid epithelial pancreatic neoplasms were evaluated for smear and cell block cellularity. Cellularity was scored on a scale of 1 to 4; scores of 3 or 4 (>100 cells) were deemed adequate for ancillary studies. Clinicopathologic variables were recorded. A 3-month prospective analysis was also performed using a new collection algorithm. Results.-Only 12.4% (21 of 169) of the positive cases had a cell block cellularity score that was adequate for theranostic studies. This score was not associated with onsite evaluation, needle gauge, or number of passes. Adenocarcinoma was the most common diagnosis (88%) but yielded fewer adequate cell blocks, P = .006. Cellularity showed correlation with endoscopists, P = .04. Tumor size and fibrosis score of resected tumors tended to correlate with cellularity, but only larger size in endocrine tumors was significantly associated with adequacy (P = .02). Standardized collection did not improve overall cell block cellularity. Conclusions.-Changes in practice, such as obtaining dedicated passes for ancillary studies, may not be enough to improve the theranostic utility of endoscopic ultrasound- guided fine-needle aspiration in pancreatic neoplasia. Other methods to improve tumor cell yield, including modified cytologic techniques and new needle designs, need to be further investigated.

AB - Context.-Novel chemotherapy regimens now provide the opportunity for "personalized" care in pancreatic cancer. Little is known about our ability to procure adequate cells for theranostic studies using standard ultrasound-guided fine-needle aspirations and cytologic techniques. Objective.-To assess cellularity of cytology material in patients with solid pancreatic lesions. Design.-One hundred sixty-nine endoscopic ultrasound- guided fine-needle aspirations with positive diagnoses of solid epithelial pancreatic neoplasms were evaluated for smear and cell block cellularity. Cellularity was scored on a scale of 1 to 4; scores of 3 or 4 (>100 cells) were deemed adequate for ancillary studies. Clinicopathologic variables were recorded. A 3-month prospective analysis was also performed using a new collection algorithm. Results.-Only 12.4% (21 of 169) of the positive cases had a cell block cellularity score that was adequate for theranostic studies. This score was not associated with onsite evaluation, needle gauge, or number of passes. Adenocarcinoma was the most common diagnosis (88%) but yielded fewer adequate cell blocks, P = .006. Cellularity showed correlation with endoscopists, P = .04. Tumor size and fibrosis score of resected tumors tended to correlate with cellularity, but only larger size in endocrine tumors was significantly associated with adequacy (P = .02). Standardized collection did not improve overall cell block cellularity. Conclusions.-Changes in practice, such as obtaining dedicated passes for ancillary studies, may not be enough to improve the theranostic utility of endoscopic ultrasound- guided fine-needle aspiration in pancreatic neoplasia. Other methods to improve tumor cell yield, including modified cytologic techniques and new needle designs, need to be further investigated.

UR - http://www.scopus.com/inward/record.url?scp=84903971369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903971369&partnerID=8YFLogxK

U2 - 10.5858/arpa.2013-0335-OA

DO - 10.5858/arpa.2013-0335-OA

M3 - Article

C2 - 24978918

AN - SCOPUS:84903971369

VL - 138

SP - 923

EP - 928

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 7

ER -